Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T70777 |
LY 202769
|
Others | Others |
LY 202769 is a cholecystokinin-B antagonist. | |||
T70775 |
Zoptarelin doxorubicin
|
||
Zoptarelin doxorubicin, also known as AEZS-108, is an LHRH agonist. Zoptarelin doxorubicin is a peptide agonist of the gonadotropin releasing hormone-1 receptor (GnRH-1R) that is conjugated to the anthracycline antibiotic doxorubicin with potential antineoplastic activity. Zoptarelin doxorubicin binds to GnRH-1Rs, which may be highly expressed on endometrial and ovarian tumor cell membrane surfaces, and is internalized. Once inside the cell, the doxorubicin moiety of this agent intercalates in... |